Severe COVID-19 infection associated with endothelial activation.
作者信息
Escher Robert, Breakey Neal, Lämmle Bernhard
机构信息
Department of Medicine, Spital Emmental, Burgdorf, Switzerland.
Department of Medicine, Spital Emmental, Burgdorf, Switzerland.
出版信息
Thromb Res. 2020 Jun;190:62. doi: 10.1016/j.thromres.2020.04.014. Epub 2020 Apr 15.
Abstract
摘要
相似文献
1
Severe COVID-19 infection associated with endothelial activation.严重的2019冠状病毒病感染与内皮细胞激活有关。
Thromb Res. 2020 Jun;190:62. doi: 10.1016/j.thromres.2020.04.014. Epub 2020 Apr 15.
2
Coagulation abnormalities and thrombosis in patients with COVID-19.新型冠状病毒肺炎患者的凝血异常与血栓形成
Lancet Haematol. 2020 Jun;7(6):e438-e440. doi: 10.1016/S2352-3026(20)30145-9. Epub 2020 May 11.
3
COVID-19 coagulopathy: an evolving story.新冠病毒感染相关凝血功能障碍：一个不断演变的故事。
Lancet Haematol. 2020 Jun;7(6):e425. doi: 10.1016/S2352-3026(20)30151-4.
4
Thromboembolic events and apparent heparin resistance in patients infected with SARS-CoV-2.感染新型冠状病毒（SARS-CoV-2）患者的血栓栓塞事件及明显的肝素抵抗
Int J Lab Hematol. 2020 Jun;42 Suppl 1(Suppl 1):19-20. doi: 10.1111/ijlh.13230.
5
COVID-19 Coagulopathy and Inflammation: The Knowns and Unknowns.新型冠状病毒肺炎凝血功能障碍与炎症：已知与未知
Anesth Analg. 2020 Nov;131(5):1323. doi: 10.1213/ANE.0000000000005215.
6
COVID-19 and thrombosis: Beyond a casual association.新型冠状病毒肺炎与血栓形成：不仅仅是偶然关联。
Med Clin (Barc). 2020 Jul 10;155(1):44. doi: 10.1016/j.medcli.2020.04.014. Epub 2020 May 11.
7
Covid-19 associated autoimmune thrombotic thrombocytopenic purpura: Report of a case.新型冠状病毒肺炎相关自身免疫性血栓性血小板减少性紫癜：一例报告
Thromb Res. 2020 Nov;195:136-138. doi: 10.1016/j.thromres.2020.07.005. Epub 2020 Jul 5.
8
Coronavirus (COVID-19), Coagulation, and Exercise: Interactions That May Influence Health Outcomes.冠状病毒（COVID-19）、凝血与运动：可能影响健康结局的相互作用。
Semin Thromb Hemost. 2020 Oct;46(7):807-814. doi: 10.1055/s-0040-1715094. Epub 2020 Sep 3.
9
COVID-19 and haemostasis: a position paper from Italian Society on Thrombosis and Haemostasis (SISET).新型冠状病毒肺炎与止血：来自意大利血栓形成与止血协会（SISET）的立场文件。
Blood Transfus. 2020 May;18(3):167-169. doi: 10.2450/2020.0083-20. Epub 2020 Apr 8.
10
A relative ADAMTS13 deficiency supports the presence of a secondary microangiopathy in COVID 19.ADAMTS13相对缺乏支持新冠病毒感染中继发性微血管病的存在。
Thromb Res. 2020 Sep;193:170-172. doi: 10.1016/j.thromres.2020.07.034. Epub 2020 Jul 18.
引用本文的文献
1
Hematologic and Immunologic Overlap Between COVID-19 and Idiopathic Pulmonary Fibrosis.新型冠状病毒肺炎与特发性肺纤维化之间的血液学和免疫学重叠
J Clin Med. 2025 Jul 24;14(15):5229. doi: 10.3390/jcm14155229.
2
Hematological Markers in Thromboembolic Events: A Comparative Study of COVID-19 and Non-COVID-19 Hospitalized Patients.血栓栓塞事件中的血液学标志物：COVID-19与非COVID-19住院患者的比较研究
J Clin Med. 2025 May 5;14(9):3192. doi: 10.3390/jcm14093192.
3
COVID-19 and acute limb ischemia: latest hypotheses of pathophysiology and molecular mechanisms.2019冠状病毒病与急性肢体缺血：病理生理学和分子机制的最新假说
J Zhejiang Univ Sci B. 2025 Feb 19;26(4):333-352. doi: 10.1631/jzus.B2300512.
4
Deep insight into cytokine storm: from pathogenesis to treatment.深入洞察细胞因子风暴：从发病机制到治疗。
Signal Transduct Target Ther. 2025 Apr 16;10(1):112. doi: 10.1038/s41392-025-02178-y.
5
Neurological sequelae of long COVID: a comprehensive review of diagnostic imaging, underlying mechanisms, and potential therapeutics.长期新冠的神经后遗症：诊断成像、潜在机制及潜在治疗方法的全面综述
Front Neurol. 2025 Feb 7;15:1465787. doi: 10.3389/fneur.2024.1465787. eCollection 2024.
6
Haematological Manifestations of SARS-CoV-2: Insights into Erythropoiesis, Hepcidin Regulation, and Cytokine Storm.新型冠状病毒肺炎的血液学表现：对红细胞生成、铁调素调节及细胞因子风暴的见解
Int J Mol Sci. 2025 Jan 21;26(3):874. doi: 10.3390/ijms26030874.
7
The Role of Heparin in Postural Orthostatic Tachycardia Syndrome and Other Post-Acute Sequelae of COVID-19.肝素在体位性直立性心动过速综合征及新冠病毒感染后急性后遗症中的作用
J Clin Med. 2024 Apr 20;13(8):2405. doi: 10.3390/jcm13082405.
8
Biomarkers of thromboinflammation correlate to COVID-19 infection and admission status in emergency department patients.血栓炎症生物标志物与急诊科患者的新冠病毒感染及入院状态相关。
Thromb Update. 2021 Dec;5:100090. doi: 10.1016/j.tru.2021.100090. Epub 2021 Nov 19.
9
[Severe bowel complications in SARS-CoV-2 patients receiving protocolized care].[接受标准化治疗的新冠病毒患者的严重肠道并发症]
Rev Gastroenterol Mex. 2021 Oct-Dec;86(4):378-386. doi: 10.1016/j.rgmx.2021.03.002. Epub 2021 Jul 2.
10
The evolution of preexisting primary immune thrombocytopenia after COVID-19 onset: A nationally representative, prospective, multicentre, observational study.COVID-19 发病后原发性免疫性血小板减少症的演变：一项全国代表性、前瞻性、多中心、观察性研究。
Ann Hematol. 2024 May;103(5):1549-1559. doi: 10.1007/s00277-024-05720-0. Epub 2024 Mar 25.
本文引用的文献
1
Incidence of thrombotic complications in critically ill ICU patients with COVID-19.COVID-19 重症监护病房危重症患者的血栓并发症发生率。
Thromb Res. 2020 Jul;191:145-147. doi: 10.1016/j.thromres.2020.04.013. Epub 2020 Apr 10.
2
Coagulopathy and Antiphospholipid Antibodies in Patients with Covid-19.新型冠状病毒肺炎患者的凝血障碍与抗磷脂抗体
N Engl J Med. 2020 Apr 23;382(17):e38. doi: 10.1056/NEJMc2007575. Epub 2020 Apr 8.
3
Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study.中国武汉成人 COVID-19 住院患者的临床病程和死亡危险因素：一项回顾性队列研究。
Lancet. 2020 Mar 28;395(10229):1054-1062. doi: 10.1016/S0140-6736(20)30566-3. Epub 2020 Mar 11.
4
Tissue distribution of ACE2 protein, the functional receptor for SARS coronavirus. A first step in understanding SARS pathogenesis.SARS冠状病毒功能性受体ACE2蛋白的组织分布。理解SARS发病机制的第一步。
J Pathol. 2004 Jun;203(2):631-7. doi: 10.1002/path.1570.
Zotero 插件